BibTex RIS Cite

Karaciğer Sirozlu Hastalarda Artmış Plazma Karnitin Seviyeleri

Year 2009, Volume: 40 Issue: 2, 41 - 44, 15.11.2013

References

  • Fritz IB. The Effects of muscle extracts on the oxidation of palmitic acid by liver slices and homogenates. Acta Physiol Scand 1955; 34: 367-385.
  • Bremer J. Carnitine-metabolism and functions. Physiol Rev1983; 63: 1420-1479.
  • Kaplan A, Batun MS, Canoruç F, Erdinç L, Canoruç N, Turgut C. Karaciğer sirozunda plazma karnitin düzey- leri. Turk J Gastroenterol 1995; 6: 350-352.
  • Amodio P, Angeli P, Markel C, Menon F, Gatta A. Plasma carnitine levels in cirrhosis: relationship with nutritional status and liver damage. J Clin Chem Clin Biochem 1990; 28: 619-626.
  • Rudman D, Sewell, CW, Ansley JD. Deficiency of car- nitine in cachectic cirrhotic patients. J Clin Invest 1977; 60: 716-723.
  • Cejka J, Kithier K. Serum carnitine quantification. Clin Chem 1992; 38: 304-305.
  • Fuller RK, Hoppel CL. levated plasma carnitine in hepatic cirrhosis. Hepatology 1983; 3: 554-558.
  • Krahenbühl S, Reichen J. Carnitine metabolism in patients with chronic liver disease. Hepatology 1997; 25: 148-153.
  • Selimoglu MA, Aydogdu S, Yagci RV, Huseyinov A. Plasma and liver carnitine status of children with chronic liver disease and cirrhosis. Pediatr Int 2001; 43: 391-395.
  • Eskandari GH, Kandemir O, Polat G, Tamer L, Ersöz G, Atik U. Serum L-carnitine levels and lipoprotein compositions in chronic viral hepatitis patients. Clin Biochem 2001; 34: 431-433.
  • Guder WG, Wagner S. The role of the kidney in car- nitine metabolism. J Clin Chem Clin Biochem 1990; 28: 347-350.
Year 2009, Volume: 40 Issue: 2, 41 - 44, 15.11.2013

References

  • Fritz IB. The Effects of muscle extracts on the oxidation of palmitic acid by liver slices and homogenates. Acta Physiol Scand 1955; 34: 367-385.
  • Bremer J. Carnitine-metabolism and functions. Physiol Rev1983; 63: 1420-1479.
  • Kaplan A, Batun MS, Canoruç F, Erdinç L, Canoruç N, Turgut C. Karaciğer sirozunda plazma karnitin düzey- leri. Turk J Gastroenterol 1995; 6: 350-352.
  • Amodio P, Angeli P, Markel C, Menon F, Gatta A. Plasma carnitine levels in cirrhosis: relationship with nutritional status and liver damage. J Clin Chem Clin Biochem 1990; 28: 619-626.
  • Rudman D, Sewell, CW, Ansley JD. Deficiency of car- nitine in cachectic cirrhotic patients. J Clin Invest 1977; 60: 716-723.
  • Cejka J, Kithier K. Serum carnitine quantification. Clin Chem 1992; 38: 304-305.
  • Fuller RK, Hoppel CL. levated plasma carnitine in hepatic cirrhosis. Hepatology 1983; 3: 554-558.
  • Krahenbühl S, Reichen J. Carnitine metabolism in patients with chronic liver disease. Hepatology 1997; 25: 148-153.
  • Selimoglu MA, Aydogdu S, Yagci RV, Huseyinov A. Plasma and liver carnitine status of children with chronic liver disease and cirrhosis. Pediatr Int 2001; 43: 391-395.
  • Eskandari GH, Kandemir O, Polat G, Tamer L, Ersöz G, Atik U. Serum L-carnitine levels and lipoprotein compositions in chronic viral hepatitis patients. Clin Biochem 2001; 34: 431-433.
  • Guder WG, Wagner S. The role of the kidney in car- nitine metabolism. J Clin Chem Clin Biochem 1990; 28: 347-350.
There are 11 citations in total.

Details

Primary Language Turkish
Journal Section Araştırmalar
Authors

Ahmet Baran This is me

Çiğdem A. Zeybek This is me

Arzu Kahveci This is me

Hasan Önal This is me

Perihan Akın This is me

Ahmet Baran Sebati Özdemir This is me

Arzu Kahveci Sema Yalvaç This is me

Ahmet Aydın Perihan Akın This is me

Publication Date November 15, 2013
Published in Issue Year 2009 Volume: 40 Issue: 2

Cite

APA Baran, A., Zeybek, Ç. A., Kahveci, A., Önal, H., et al. (2013). Karaciğer Sirozlu Hastalarda Artmış Plazma Karnitin Seviyeleri. Cerrahpaşa Tıp Dergisi, 40(2), 41-44.
AMA Baran A, Zeybek ÇA, Kahveci A, Önal H, Akın P, Sebati Özdemir AB, Sema Yalvaç AK, Perihan Akın AA. Karaciğer Sirozlu Hastalarda Artmış Plazma Karnitin Seviyeleri. Cerrahpaşa Tıp Dergisi. November 2013;40(2):41-44.
Chicago Baran, Ahmet, Çiğdem A. Zeybek, Arzu Kahveci, Hasan Önal, Perihan Akın, Ahmet Baran Sebati Özdemir, Arzu Kahveci Sema Yalvaç, and Ahmet Aydın Perihan Akın. “Karaciğer Sirozlu Hastalarda Artmış Plazma Karnitin Seviyeleri”. Cerrahpaşa Tıp Dergisi 40, no. 2 (November 2013): 41-44.
EndNote Baran A, Zeybek ÇA, Kahveci A, Önal H, Akın P, Sebati Özdemir AB, Sema Yalvaç AK, Perihan Akın AA (November 1, 2013) Karaciğer Sirozlu Hastalarda Artmış Plazma Karnitin Seviyeleri. Cerrahpaşa Tıp Dergisi 40 2 41–44.
IEEE A. Baran, Ç. A. Zeybek, A. Kahveci, H. Önal, P. Akın, A. B. Sebati Özdemir, A. K. Sema Yalvaç, and A. A. Perihan Akın, “Karaciğer Sirozlu Hastalarda Artmış Plazma Karnitin Seviyeleri”, Cerrahpaşa Tıp Dergisi, vol. 40, no. 2, pp. 41–44, 2013.
ISNAD Baran, Ahmet et al. “Karaciğer Sirozlu Hastalarda Artmış Plazma Karnitin Seviyeleri”. Cerrahpaşa Tıp Dergisi 40/2 (November 2013), 41-44.
JAMA Baran A, Zeybek ÇA, Kahveci A, Önal H, Akın P, Sebati Özdemir AB, Sema Yalvaç AK, Perihan Akın AA. Karaciğer Sirozlu Hastalarda Artmış Plazma Karnitin Seviyeleri. Cerrahpaşa Tıp Dergisi. 2013;40:41–44.
MLA Baran, Ahmet et al. “Karaciğer Sirozlu Hastalarda Artmış Plazma Karnitin Seviyeleri”. Cerrahpaşa Tıp Dergisi, vol. 40, no. 2, 2013, pp. 41-44.
Vancouver Baran A, Zeybek ÇA, Kahveci A, Önal H, Akın P, Sebati Özdemir AB, Sema Yalvaç AK, Perihan Akın AA. Karaciğer Sirozlu Hastalarda Artmış Plazma Karnitin Seviyeleri. Cerrahpaşa Tıp Dergisi. 2013;40(2):41-4.